Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7688 |
Intermediate Similarity |
NPD2842 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD814 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD5183 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5186 |
Approved |
0.7247 |
Intermediate Similarity |
NPD1012 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD1769 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD3793 |
Phase 3 |
0.7173 |
Intermediate Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD1305 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD6037 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD5680 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4859 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD5900 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD6644 |
Discontinued |
0.6963 |
Remote Similarity |
NPD6021 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD5620 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5071 |
Phase 2 |
0.6915 |
Remote Similarity |
NPD5521 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD5560 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD5600 |
Discontinued |
0.6907 |
Remote Similarity |
NPD2843 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD2845 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6888 |
Remote Similarity |
NPD4591 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD4590 |
Approved |
0.6888 |
Remote Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.6882 |
Remote Similarity |
NPD4083 |
Discontinued |
0.6882 |
Remote Similarity |
NPD2215 |
Approved |
0.6882 |
Remote Similarity |
NPD2216 |
Approved |
0.6834 |
Remote Similarity |
NPD4668 |
Phase 2 |
0.6827 |
Remote Similarity |
NPD4562 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6808 |
Remote Similarity |
NPD3912 |
Discontinued |
0.6802 |
Remote Similarity |
NPD7262 |
Phase 1 |
0.68 |
Remote Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD5547 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD1294 |
Discontinued |
0.6784 |
Remote Similarity |
NPD4979 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD4597 |
Approved |
0.6782 |
Remote Similarity |
NPD4598 |
Approved |
0.678 |
Remote Similarity |
NPD5658 |
Approved |
0.6778 |
Remote Similarity |
NPD6357 |
Discontinued |
0.6778 |
Remote Similarity |
NPD789 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD3983 |
Phase 3 |
0.6772 |
Remote Similarity |
NPD4354 |
Approved |
0.6766 |
Remote Similarity |
NPD1740 |
Approved |
0.6766 |
Remote Similarity |
NPD1739 |
Approved |
0.6757 |
Remote Similarity |
NPD4796 |
Discontinued |
0.6757 |
Remote Similarity |
NPD2190 |
Approved |
0.6755 |
Remote Similarity |
NPD2248 |
Approved |
0.6755 |
Remote Similarity |
NPD2246 |
Approved |
0.6745 |
Remote Similarity |
NPD5433 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD19 |
Approved |
0.6739 |
Remote Similarity |
NPD1742 |
Approved |
0.6739 |
Remote Similarity |
NPD1743 |
Approved |
0.6737 |
Remote Similarity |
NPD5670 |
Approved |
0.6735 |
Remote Similarity |
NPD7630 |
Phase 3 |
0.6735 |
Remote Similarity |
NPD7629 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD7628 |
Phase 3 |
0.6732 |
Remote Similarity |
NPD2758 |
Phase 1 |
0.6719 |
Remote Similarity |
NPD7149 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD6874 |
Approved |
0.6716 |
Remote Similarity |
NPD4795 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD850 |
Approved |
0.6707 |
Remote Similarity |
NPD848 |
Approved |
0.6707 |
Remote Similarity |
NPD849 |
Approved |
0.6701 |
Remote Similarity |
NPD5641 |
Discontinued |
0.67 |
Remote Similarity |
NPD3515 |
Approved |
0.67 |
Remote Similarity |
NPD3516 |
Approved |
0.6684 |
Remote Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD4012 |
Approved |
0.6667 |
Remote Similarity |
NPD3301 |
Approved |
0.6667 |
Remote Similarity |
NPD6877 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6031 |
Approved |
0.6667 |
Remote Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6030 |
Approved |
0.6651 |
Remote Similarity |
NPD5632 |
Approved |
0.665 |
Remote Similarity |
NPD6238 |
Discontinued |
0.6649 |
Remote Similarity |
NPD5810 |
Discontinued |
0.6649 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.6634 |
Remote Similarity |
NPD4467 |
Phase 2 |
0.6634 |
Remote Similarity |
NPD4465 |
Phase 2 |
0.6634 |
Remote Similarity |
NPD1768 |
Approved |
0.6633 |
Remote Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD2525 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.6632 |
Remote Similarity |
NPD7032 |
Approved |
0.663 |
Remote Similarity |
NPD3562 |
Approved |
0.663 |
Remote Similarity |
NPD3564 |
Approved |
0.663 |
Remote Similarity |
NPD3563 |
Approved |
0.6629 |
Remote Similarity |
NPD7753 |
Approved |
0.6629 |
Remote Similarity |
NPD7752 |
Approved |
0.6618 |
Remote Similarity |
NPD4154 |
Approved |
0.6618 |
Remote Similarity |
NPD4082 |
Approved |
0.6617 |
Remote Similarity |
NPD4604 |
Approved |
0.6617 |
Remote Similarity |
NPD4605 |
Approved |
0.6615 |
Remote Similarity |
NPD795 |
Clinical (unspecified phase) |
0.6615 |
Remote Similarity |
NPD1716 |
Phase 3 |
0.6612 |
Remote Similarity |
NPD4205 |
Phase 3 |
0.6603 |
Remote Similarity |
NPD1945 |
Phase 1 |
0.6602 |
Remote Similarity |
NPD3003 |
Approved |
0.6601 |
Remote Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD5188 |
Clinical (unspecified phase) |
0.6598 |
Remote Similarity |
NPD1909 |
Discontinued |
0.6597 |
Remote Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.6596 |
Remote Similarity |
NPD2681 |
Approved |
0.6596 |
Remote Similarity |
NPD2680 |
Approved |
0.6589 |
Remote Similarity |
NPD6633 |
Phase 2 |
0.6589 |
Remote Similarity |
NPD5930 |
Phase 3 |
0.6589 |
Remote Similarity |
NPD6634 |
Clinical (unspecified phase) |
0.6583 |
Remote Similarity |
NPD5937 |
Approved |
0.6583 |
Remote Similarity |
NPD4740 |
Approved |
0.6578 |
Remote Similarity |
NPD7392 |
Phase 2 |
0.6571 |
Remote Similarity |
NPD4492 |
Approved |
0.6571 |
Remote Similarity |
NPD4494 |
Approved |
0.6566 |
Remote Similarity |
NPD5928 |
Phase 1 |
0.6562 |
Remote Similarity |
NPD5334 |
Clinical (unspecified phase) |
0.6556 |
Remote Similarity |
NPD1424 |
Approved |
0.6553 |
Remote Similarity |
NPD5102 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD2151 |
Approved |
0.6543 |
Remote Similarity |
NPD2162 |
Clinical (unspecified phase) |
0.6541 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6537 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD7238 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD2476 |
Clinical (unspecified phase) |
0.6526 |
Remote Similarity |
NPD3440 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD1309 |
Phase 2 |
0.6524 |
Remote Similarity |
NPD1307 |
Phase 2 |
0.6524 |
Remote Similarity |
NPD3570 |
Phase 2 |
0.6524 |
Remote Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD4201 |
Clinical (unspecified phase) |
0.6517 |
Remote Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD3253 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD6461 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD3783 |
Clinical (unspecified phase) |
0.6508 |
Remote Similarity |
NPD4986 |
Clinical (unspecified phase) |
0.6508 |
Remote Similarity |
NPD3511 |
Discontinued |
0.6507 |
Remote Similarity |
NPD4710 |
Clinical (unspecified phase) |
0.6503 |
Remote Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD3153 |
Approved |
0.6497 |
Remote Similarity |
NPD3154 |
Approved |
0.6497 |
Remote Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.6495 |
Remote Similarity |
NPD2168 |
Clinical (unspecified phase) |
0.6495 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6495 |
Remote Similarity |
NPD2167 |
Clinical (unspecified phase) |
0.649 |
Remote Similarity |
NPD5143 |
Clinical (unspecified phase) |
0.6486 |
Remote Similarity |
NPD1861 |
Discovery |
0.6477 |
Remote Similarity |
NPD3156 |
Discontinued |
0.6474 |
Remote Similarity |
NPD4166 |
Phase 2 |
0.6468 |
Remote Similarity |
NPD5610 |
Approved |
0.6468 |
Remote Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.6468 |
Remote Similarity |
NPD1038 |
Approved |
0.6462 |
Remote Similarity |
NPD5944 |
Phase 1 |
0.6462 |
Remote Similarity |
NPD5945 |
Phase 1 |
0.6459 |
Remote Similarity |
NPD3472 |
Approved |
0.6459 |
Remote Similarity |
NPD4022 |
Approved |
0.6457 |
Remote Similarity |
NPD2951 |
Discontinued |
0.6453 |
Remote Similarity |
NPD2952 |
Discontinued |
0.6453 |
Remote Similarity |
NPD5195 |
Discontinued |
0.6452 |
Remote Similarity |
NPD6737 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD6738 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD5294 |
Clinical (unspecified phase) |
0.6449 |
Remote Similarity |
NPD6719 |
Approved |
0.6447 |
Remote Similarity |
NPD4586 |
Phase 3 |
0.6445 |
Remote Similarity |
NPD4493 |
Discontinued |
0.6445 |
Remote Similarity |
NPD683 |
Approved |
0.6439 |
Remote Similarity |
NPD5497 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD9694 |
Discovery |
0.6435 |
Remote Similarity |
NPD6242 |
Discontinued |
0.6432 |
Remote Similarity |
NPD2469 |
Approved |
0.6432 |
Remote Similarity |
NPD4113 |
Discontinued |
0.6432 |
Remote Similarity |
NPD5903 |
Approved |
0.6432 |
Remote Similarity |
NPD2468 |
Approved |
0.6432 |
Remote Similarity |
NPD3349 |
Phase 2 |
0.6432 |
Remote Similarity |
NPD5902 |
Approved |
0.6429 |
Remote Similarity |
NPD1381 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD4437 |
Phase 3 |
0.6429 |
Remote Similarity |
NPD2166 |
Phase 3 |
0.6425 |
Remote Similarity |
NPD5754 |
Discontinued |
0.6425 |
Remote Similarity |
NPD7064 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD5194 |
Approved |
0.6422 |
Remote Similarity |
NPD5197 |
Approved |
0.6422 |
Remote Similarity |
NPD5196 |
Approved |
0.6417 |
Remote Similarity |
NPD3558 |
Approved |
0.6417 |
Remote Similarity |
NPD3556 |
Approved |
0.6417 |
Remote Similarity |
NPD3557 |
Approved |
0.6417 |
Remote Similarity |
NPD3559 |
Clinical (unspecified phase) |
0.6417 |
Remote Similarity |
NPD3560 |
Approved |
0.6416 |
Remote Similarity |
NPD2245 |
Discovery |
0.6414 |
Remote Similarity |
NPD5256 |
Discontinued |
0.6411 |
Remote Similarity |
NPD4596 |
Phase 1 |
0.6411 |
Remote Similarity |
NPD1392 |
Approved |
0.641 |
Remote Similarity |
NPD2169 |
Clinical (unspecified phase) |
0.6409
|
Remote Similarity |
NPD1802 |
Approved |